LifeMD Reviews
Honest patient reviews and ratings for LifeMD peptide therapy services.
Telehealth Ally is editorially independent. Revenue never influences our rankings.
Our Verdict
LifeMD earns a 4.0/5 rating from 11 patient reviews, with pricing starting at $299/month. They offer video telehealth consultations.
Quick Facts
Consultation
Video Telehealth
Lab Testing
Not included
Peptides Offered
2
Shipping
3-7 business days
LifeMD Review 2026: Brand-Name GLP-1 Access, Pricing & How It Compares
Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026.
Most telehealth GLP-1 platforms built their business around compounded semaglutide. LifeMD built theirs around something harder to replicate: direct commercial agreements with Novo Nordisk and Eli Lilly. That means patients who qualify can access brand-name Wegovy and Zepbound at negotiated prices — not just compounded alternatives from a 503B pharmacy. As the FDA continues restricting compounded GLP-1 supply, that distinction matters more than it did a year ago. LifeMD (NASDAQ: LFMD) also accepts most major PPO insurance plans and handles prior authorization in-house, making it one of the few telehealth platforms where insured patients can get GLP-1 medications through their health plan rather than paying cash for a compounded version.
What does LifeMD offer?
LifeMD is a publicly traded multi-brand telehealth company headquartered in New York. It reported $194.1 million in 2025 revenue, a 25% year-over-year increase. Unlike startups in this space, LifeMD's finances are publicly audited and subject to SEC oversight.
The company operates several branded services under one corporate umbrella — Rex MD for men's health, Nava MD for women's health, Shapiro MD for hair loss, and the core LifeMD platform for primary care and weight management. All of these are the same company. If you see a prescription from Rex MD or Nava MD, it is routed through the same provider network and infrastructure.
For weight loss, LifeMD offers the broadest branded GLP-1 menu of any telehealth platform operating today:
- Brand Wegovy (semaglutide injection) — Via direct Novo Nordisk partnership
- Wegovy pill (oral semaglutide, 4mg) — The first FDA-approved GLP-1 pill for weight loss
- Wegovy pill (oral semaglutide, 9–25mg) — Higher oral doses
- Wegovy HD (semaglutide 7.2mg injection) — Higher-dose injectable approved March 19, 2026; pharmacy launch expected April 2026
- Brand Zepbound (tirzepatide vials) — Via Eli Lilly/LillyDirect partnership
- Orforglipron — Oral GLP-1 pill via LillyDirect partnership; awaiting FDA approval (PDUFA date: April 10, 2026)
- Ozempic (semaglutide) — Available off-label for weight management
- Saxenda (liraglutide) — For patients who don't qualify for newer GLP-1s
- Triple Therapy — Metformin + bupropion + topiramate (non-GLP-1 oral option at $129/mo)
One notable absence: LifeMD no longer offers compounded GLP-1 medications. The compounded market has largely been wound down under FDA enforcement pressure, and LifeMD has transitioned fully to manufacturer-partnership branded products.
Pricing last verified April 2026. We update pricing data monthly. Contact us if you spot an error.
How much does LifeMD cost per month?
LifeMD's all-in monthly cost ranges from $204/month (Triple Therapy self-pay) to $574–$648/month (brand-name injectables self-pay), or as low as $29/month for insured patients whose plan covers Wegovy. LifeMD uses a two-part pricing model: a program fee plus medication cost. Both need to be added to get the real number.
| Component | Monthly Cost | Notes |
|---|---|---|
| Program fee (annual plan) | $75/mo | Introductory rate; standard is up to $149/mo |
| Program fee (with qualifying insurance) | $29/mo | For patients with PPO plans accepted by LifeMD |
| Wegovy injection | $499/mo (self-pay) | As low as $0 with insurance |
| Wegovy pill (4mg) | ~$199/mo | Oral formulation |
| Wegovy pill (9–25mg) | ~$299/mo | Higher oral doses |
| Wegovy HD (7.2mg) | TBD | Pharmacy launch expected April 2026 |
| Zepbound (2.5mg) | $349/mo | Via LillyDirect |
| Zepbound (5mg+) | $499/mo | Via LillyDirect |
| Orforglipron | $149/mo (announced) | Pending FDA approval (PDUFA April 10, 2026) |
| Triple Therapy | $129/mo | Non-GLP-1 oral option |
| Video visit | $50 | Cash or copay |
Total monthly cost without insurance: Adding the $75/mo program fee to medication costs puts all-in pricing at:
- Triple Therapy: $204/mo
- Orforglipron (if approved): $224/mo (announced)
- Wegovy pill (4mg): $274/mo
- Zepbound (2.5mg): $424/mo
- Wegovy injection / Zepbound (5mg+): $574–$648/mo
Total monthly cost with insurance: For patients with PPO coverage, the program fee drops to $29/mo. Wegovy may cost as little as $0 with a qualifying plan, making the all-in cost potentially under $30/month for insured patients — lower than most telehealth competitors' compounded pricing.
For comparison: Hims charges $199/mo for compounded semaglutide and Ro charges $149/mo for compounded semaglutide. Neither of those includes insurance processing, prior authorization support, or access to brand-name medications. For patients asking how to get GLP-1 without insurance, LifeMD's orforglipron launch at $224/mo total would be the most affordable brand-name option.
How does LifeMD's program work?
LifeMD offers both video and async consultations — patients choose which fits their schedule.
-
Online intake — Complete a health assessment covering medical history, current medications, BMI, and weight loss goals. The intake screens for GLP-1 contraindications, including personal or family history of medullary thyroid carcinoma and MEN 2 syndrome.
-
Provider review — A licensed provider evaluates your submission. Video consultations are available within 1 hour; async review is typically returned within 4 hours.
-
Treatment plan and prescription — If approved, the provider develops a personalized treatment plan. Medications either ship directly or route through LillyDirect (for Zepbound and orforglipron).
-
Insurance navigation — For patients with PPO coverage, LifeMD's care coordination team handles prior authorization paperwork — submitting appeals, coordinating with insurers, and managing the back-and-forth that typically falls on the patient.
-
Ongoing care — 24/7 provider access via messaging; scheduled video visits as needed at $50 per session. LifeMD also includes "6S" wellness check-ins covering sleep, stress, social health, substance use, safety, and sexual health.
-
Lab work — Lab monitoring is available through Labcorp and Quest Diagnostics partnerships at no additional cost. Most GLP-1 telehealth platforms do not include this.
What is LifeMD's brand-name access advantage?
LifeMD's direct manufacturer partnerships bypass the compounding regulatory problem entirely, giving it an edge that most competitors cannot replicate. Most telehealth GLP-1 platforms operate on a single track: prescribe compounded semaglutide or tirzepatide from a 503B outsourcing facility, ship it to patients. That model has faced significant regulatory pressure. The FDA has restricted compounded semaglutide supply repeatedly since late 2024 as it moves to eliminate shortage exemptions that made compounding legal during supply disruptions.
Because LifeMD has commercial agreements with Novo Nordisk and Eli Lilly, it can write prescriptions for finished, FDA-approved Wegovy and Zepbound at prices negotiated with the manufacturer — not at the full $1,300+/month retail price that made these medications inaccessible before telehealth.
For patients who have or want to pursue PPO insurance coverage, this is a significant advantage. LifeMD handles the prior authorization process, which involves paperwork, appeals, and coordination between the provider, insurer, and pharmacy that most patients find time-consuming or impenetrable. Many telehealth competitors that only offer compounded medications cannot file insurance claims at all — compounded drugs are not reimbursable under most health plans.
The practical benefit: if your plan covers Wegovy or Zepbound at a $0–$75/mo copay, and LifeMD reduces the program fee to $29/mo for insured patients, your total monthly cost can fall well below what you would pay for compounded alternatives at cash-pay competitors.
What are the pros and cons of LifeMD?
| Pros | Cons |
|---|---|
| Direct Novo Nordisk + Eli Lilly partnerships — access to brand-name Wegovy and Zepbound | Expensive without insurance — $424–$648/mo for injectables is among the highest in telehealth |
| Accepts most major PPO plans; handles prior authorization | Program fee is separate from medication cost — easy to miss in pricing comparisons |
| Video consultations available within 1 hour | No compounded GLP-1 options — patients who want lower-cost alternatives must go elsewhere |
| Lab work included through Labcorp/Quest | Government insurance (Medicare, Medicaid) not accepted for the GLP-1 weight loss program |
| 10% body weight loss guarantee with refund eligibility | Multiple sub-brands (Rex MD, Nava MD) can confuse patients who don't know they're the same company |
| Wegovy pill option for patients who prefer oral dosing over injection | BBB complaints on pricing clarity and billing |
| Publicly traded (NASDAQ: LFMD) with audited financials | Complex corporate history and multiple rebrandings may give some patients pause |
| 50-state availability | |
| Widest branded GLP-1 menu in telehealth (Wegovy in multiple doses/forms + Zepbound + orforglipron) |
Who is LifeMD best for?
Patients with PPO insurance that covers GLP-1 medications. LifeMD's combination of insurance acceptance, in-house prior authorization support, and direct manufacturer access makes it uniquely positioned for patients who have (or are willing to pursue) coverage. If your plan covers Wegovy or Zepbound, LifeMD can make those medications genuinely affordable — potentially $29/month plus a modest copay.
Patients who want brand-name medications without insurance. Self-pay patients who specifically want brand-name products at non-retail prices, and who can afford the $224–$648/mo range, will find the widest branded selection here.
Patients who want clinical depth. The combination of same-day video availability, lab work, 24/7 async messaging, and wellness check-ins represents more clinical infrastructure than most GLP-1 telehealth platforms. If you want to feel like you're actually under medical supervision rather than just receiving a prescription, LifeMD is a better fit than the lean async-only platforms.
Patients interested in the Wegovy pill. Oral semaglutide (Wegovy pill) was approved by the FDA for weight loss and is one of the few injection-free brand-name GLP-1 options available. LifeMD offers it; most competitors do not.
Who should look elsewhere?
Cash-pay patients who want the cheapest option. If price is the primary factor and you're paying out of pocket, LifeMD's injectable prices ($424–$648/mo all-in) are among the highest in telehealth. Henry Meds ($149/mo compounded semaglutide) or Ro ($149/mo) are significantly cheaper, though they do not offer brand-name medications.
Patients on Medicare or Medicaid. LifeMD explicitly does not accept government insurance for the GLP-1 weight loss program. Patients who are eligible for the Medicare GLP-1 Bridge Program ($50/mo copay) should look at platforms that accept Medicare.
Patients who want a structured coaching program. LifeMD's model is medication-first with clinical oversight. Platforms like Found or Calibrate offer more behavioral coaching and lifestyle program structure alongside medication. If coaching and accountability tools are important to you, those programs may be a better fit.
How does LifeMD compare to Hims and Ro?
The most direct competitors at the telehealth GLP-1 market's mass end are Hims and Ro. Both are larger consumer brands; both built their GLP-1 business primarily around compounded semaglutide.
The key difference is medication access. Hims and Ro have historically focused on compounded GLP-1s, and their brand-name options are limited or require insurance navigation that happens outside their core product experience. LifeMD built its clinical infrastructure around direct manufacturer partnerships from the start. This means:
- LifeMD can write for Wegovy, Wegovy pill, Zepbound, and (pending approval) orforglipron on a single platform with unified care management. Neither Hims nor Ro currently offers this breadth.
- LifeMD handles prior authorization in-house. This is not a peripheral feature — it is a meaningful amount of clinical and administrative work that saves patients hours of phone calls.
- LifeMD is more expensive if you are self-pay and only want injectable semaglutide. Hims at $199/mo and Ro at $149/mo are meaningfully cheaper if you are comfortable with a compounded formulation.
For patients with insurance, LifeMD is likely the better platform. For price-sensitive self-pay patients who are comfortable with compounded semaglutide and do not require video visits or lab work, Ro or Henry Meds may offer a lower-cost path. Patients searching for the cheapest way to get semaglutide online will find Ro or Henry Meds more relevant; patients who want brand-name medications with real clinical infrastructure will find LifeMD the better-equipped option.
April 2026 Context
The GLP-1 telehealth market looks different in April 2026 than it did at the start of 2025. The FDA has moved aggressively to restrict compounded GLP-1 supply, eliminating the shortage-based exemptions that allowed 503B compounders to produce semaglutide and tirzepatide at scale. This has forced several platforms that relied heavily on compounded supply to restructure, raise prices, or exit the market.
LifeMD's brand-name access has become more valuable in this environment. The platforms that are best positioned now are those that either have manufacturer relationships or can reliably navigate patients to insured brand-name medications — and LifeMD is one of the few that can do both.
Two additional developments are worth watching. First, Wegovy HD (semaglutide 7.2mg), approved March 19, 2026, gives patients who have reached the standard Wegovy ceiling a higher-efficacy option available through LifeMD's existing Novo Nordisk relationship. Second, orforglipron — Eli Lilly's oral GLP-1 pill — has a PDUFA date of April 10, 2026. If approved, LifeMD has announced a $149/mo price via its LillyDirect partnership. At $149/mo for medication plus $75/mo program fee, orforglipron would be LifeMD's most affordable self-pay path at $224/mo total — competitive with compounded pricing at other platforms, but with a brand-name, FDA-approved product and no compounding risk.
Is LifeMD worth it?
LifeMD is two different platforms depending on how you're paying. For insured patients with PPO coverage, it may be the most affordable comprehensive GLP-1 program in telehealth. The combination of insurance acceptance, prior authorization management, and manufacturer partnerships means patients who do the work to get coverage can access brand-name Wegovy or Zepbound for potentially less than what competitors charge for compounded alternatives. Insured patients who want prior authorization handled for them will not find a better-equipped platform in telehealth.
For self-pay patients, the math is harder. Brand-name injectable medications at $424–$648/mo put LifeMD well above the cash-pay competition, and the two-part pricing model (program fee plus medication cost) makes direct comparisons easier to miss. The expected orforglipron path at $224/mo would change this calculus — a brand-name oral GLP-1 at competitive compounded pricing is a new option in this market. But that price depends on FDA approval (April 10, 2026) and can change.
What does not change is LifeMD's structural advantage: it holds commercial agreements with both major GLP-1 manufacturers, accepts insurance, handles prior authorization in-house, and can provide same-day video care with lab monitoring. No other telehealth platform currently offers all of these on a single platform. The 10% weight loss guarantee is a differentiator; the public company transparency is a floor of accountability that private startups cannot match.
Bottom line: LifeMD earns its premium for insured patients and those who want brand-name medications with real clinical infrastructure. Self-pay patients on a budget will find cheaper options, though the orforglipron launch (if approved) may narrow that gap. Whether LifeMD is worth it depends almost entirely on your insurance situation.
Rating: 4.2/5
Frequently Asked Questions
Is LifeMD legit? Yes. LifeMD (NASDAQ: LFMD) is a publicly traded company with SEC-audited financials and direct commercial partnerships with Novo Nordisk and Eli Lilly. It is one of the most credentialed telehealth GLP-1 platforms operating today.
How much does LifeMD cost without insurance? Self-pay patients pay a $75/mo program fee plus medication cost. All-in, that ranges from $204/mo (Triple Therapy) to $574–$648/mo for brand-name injectables. The announced orforglipron path (pending FDA approval) would cost $224/mo total.
Does LifeMD take insurance? Yes. LifeMD accepts most major PPO plans and handles prior authorization in-house. The program fee drops to $29/mo for qualifying insured patients. It does not accept Medicare or Medicaid for the GLP-1 weight loss program.
How do I cancel LifeMD? You can cancel through the patient portal or by contacting LifeMD customer support. Note that LifeMD has received some BBB complaints about billing and pricing clarity — confirm cancellation terms before you enroll.
Is LifeMD's semaglutide FDA-approved? LifeMD no longer offers compounded semaglutide. They prescribe brand-name Wegovy, which is FDA-approved for weight management, obtained through their direct Novo Nordisk partnership.
How does LifeMD compare to Ro for GLP-1? Ro charges $149/mo for compounded semaglutide but does not have manufacturer partnerships or in-house prior authorization. LifeMD costs more for self-pay patients but offers brand-name medications, insurance acceptance, and more comprehensive clinical care.
Is LifeMD the best online GLP-1 program for insured patients? For patients with PPO coverage, LifeMD is one of the strongest options — the combination of insurance navigation, direct manufacturer access, and clinical depth (including same-day video and lab work) is rare among telehealth platforms.
Data Sources & Methodology
Pricing and protocol data sourced from LifeMD's public website and verified via checkout flow, April 2026. Patient experience data drawn from public reviews (Google, Trustpilot, Reddit) and independent patient outreach. Telehealth Ally has no commercial relationship with this provider. Rankings and ratings are editorial-only.
Related Resources
- Does Insurance Cover GLP-1 Medications? — Coverage rules, what qualifies, what to expect
- GLP-1 Prior Authorization & Insurance Guide — How to navigate PA and get approved
- LifeMD vs Hims Weight Loss — Side-by-side comparison
- LifeMD vs Ro Weight Loss — LifeMD's clinical model vs Ro's budget approach
- Best GLP-1 Weight Loss Programs 2026 — All major providers ranked
- How Much Does Semaglutide Cost? — Real pricing across platforms
- Who Qualifies for GLP-1 Medications? — BMI, comorbidities, and eligibility criteria
Sarah Chen
Lead Health Editor
Sarah covers telehealth and digital health access. She has spent 8 years in health journalism, previously writing for health policy publications. She leads editorial at Telehealth Ally.
All Patient Reviews (11)
Provider quality is uneven — first visit was excellent, follow-up was rushed
My onboarding video consult at LifeMD was one of the better experiences I've had with telehealth — detailed, unhurried, thorough questions about my history. My follow-up call at the two-month mark felt like a completely different service. The provider had eight minutes for me, didn't reference my notes, and when I mentioned some nausea at 0.5mg she simply said to reduce back to 0.25mg without explaining anything. I ended up messaging the portal afterward to get real guidance. The medication has been working — down 9 lbs in 10 weeks — so I'm sticking with it, but the consistency of provider interactions needs work. The nationwide coverage was genuinely useful when I visited family in Wyoming.
March 20, 2026
Video consult on day one felt like actual medicine
I'd done two async GLP-1 services before LifeMD and they both felt like getting a prescription from a vending machine. LifeMD scheduled me for a video consult within 48 hours. The provider spent about 20 minutes with me, asked real questions about my history with thyroid issues, and explained why they were starting at 0.25mg instead of jumping higher. That conversation alone made me trust the program. I'm five months in, down 26 lbs, and my tirzepatide titration has been handled through follow-up video calls whenever I needed a dose review. The medication ships fast — every refill within 6 days.
March 18, 2026
No labs means I was flying blind for four months
I have pre-diabetes and was hoping a GLP-1 program would help me get my A1c down alongside the weight loss. LifeMD doesn't include any lab testing and when I asked my provider on the video consult whether they could order labs, she said I'd need to arrange that through my primary care doctor. My PCP doesn't have availability for three months. I ended up paying $85 out of pocket for a third-party lab draw just to get a baseline. The medication side hasn't been bad — I'm down 8 lbs in four months on semaglutide — but four months in and I still have no clinical data on whether my metabolic markers are actually improving. For a metabolic health program, that feels like a fundamental gap. There are other services that include labs for a comparable price.
March 8, 2026
Strong program — the no-labs piece is the only thing I wish were different
Everything about LifeMD has been good. Video consult was thorough, provider messaging is responsive, shipping is reliable. I'm four months in on tirzepatide and down 22 lbs. The reason I'm not at five stars: they don't include any lab testing. For a GLP-1 program that's monitoring metabolic health, I expected at least a basic lipid panel and A1c at the start. I had to schedule that separately through my PCP and pay a copay for the draw. It's not a dealbreaker but it's a gap when programs like Calibrate include labs in the price. If LifeMD added even an optional lab package I'd upgrade my rating.
March 2, 2026
Straightforward GLP-1 access
If you just want semaglutide or tirzepatide without the upsells, LifeMD is solid. Video call was quick, prescription shipped in a few days. Don't come here for other peptides though.
March 1, 2026
Down 34 lbs since September — tirzepatide changed everything
I'd been reading about tirzepatide for months but couldn't get it through my regular doctor. LifeMD had me approved and shipping within five days of my video consult. Started at 2.5mg in September, currently at 10mg, and I'm down 34 lbs. The cravings for late-night eating are almost entirely gone. My LifeMD provider has been responsive on messaging between visits — I had a question about nausea at the 5mg jump and got a call back within a few hours. Works in all 50 states which mattered because I travel constantly for work and wanted to make sure I could keep getting refills from Georgia or wherever.
February 26, 2026
Decent program but getting labs done separately added real friction
My first video consult was fine and the medication has been doing its job — I'm down 11 lbs in four months on semaglutide. But twice now my LifeMD provider has recommended I get lab work done to check my thyroid and lipids and both times I had to manage that entirely on my own through a separate lab service. One result didn't come back in the format they needed, which caused a delay in my refill. I understand they don't offer in-house labs but when a provider orders something and then can't receive the results in a streamlined way, the coordination burden lands on the patient. Solid medication delivery, but the lab gap is a real inconvenience.
February 17, 2026
Being publicly traded made me trust them more than the fly-by-nights
There are a lot of GLP-1 telehealth startups and I was nervous about picking one that might disappear. LifeMD is on NASDAQ, they publish earnings, they're not going anywhere. That stability mattered to me when committing to a long-term medication. The video consult model is also a big deal — my provider explained the compounded semaglutide sourcing clearly and answered my questions about the pharmacy they use. I started at 0.5mg in November, I'm at 1mg now, and I've lost 21 lbs. Shipping has been consistently 5-7 days. The service feels more professional than any of the cheaper async-only options I tried.
February 8, 2026
Video consult scheduling was slower than expected but worth the wait
I signed up expecting a video consult within a day or two. It took four days to get scheduled, which made me nervous. Once I got on the call though, the provider was excellent — spent 30 minutes reviewing my history and was upfront that my starting dose would be conservative given a family history of pancreatitis. I've been on tirzepatide for three months, up to 5mg now, and I'm down 14 lbs. Response times on the patient portal for follow-up questions have been same-day or next-day. I'd recommend the program to anyone in my situation. The scheduling lag at the start is just worth flagging so you don't have unrealistic expectations.
January 29, 2026
Finally found a telehealth company that takes video consults seriously
I specifically looked for a GLP-1 service that included video visits because I have a complicated medication history and I needed to actually talk to a provider, not just answer a questionnaire. LifeMD delivered. My onboarding consult was 25 minutes with a nurse practitioner who was clearly prepared. I've had three follow-up video visits over four months. I'm down 19 lbs on semaglutide at 1mg weekly. The nationwide availability meant my sister in Montana could join the same program when I told her about it — most services don't serve Montana. No labs is the only real gap but I get those through my PCP anyway.
January 15, 2026
GLP-1 program works well — wish they offered peptides beyond semaglutide and tirzepatide
I came to LifeMD for semaglutide and it's been a good experience — video consult was easy to book, provider was knowledgeable, I've lost 16 lbs in 3.5 months. But I was hoping to add BPC-157 for joint recovery after my results stabilize and LifeMD only offers GLP-1. I'll need to find a second provider for that. For what they do focus on, they do it well. Nationwide availability is a genuine plus — I've had friends in rural states get rejected by other programs and LifeMD serves them fine. Rating four stars because the limited catalog isn't right for people who want a broader peptide program.
December 27, 2025
Frequently Asked Questions
Is LifeMD legit?
LifeMD has 11 patient reviews with an average rating of 4.0/5. They offer video telehealth consultations. Founded in 2020, they are based in New York, NY.
How much does LifeMD cost?
LifeMD pricing starts at $299/month. They offer 2 peptides including Semaglutide, Tirzepatide.
What peptides does LifeMD offer?
LifeMD offers 2 peptides: Semaglutide, Tirzepatide.
Have you used LifeMD?
Share your honest experience to help others make informed decisions. Verified reviews are prioritized — we'll ask you to confirm via email.
Get weekly GLP-1 pricing updates
We track prices so you don't have to.
No spam. Unsubscribe anytime.
Related Guides
Best Telehealth Providers for Tirzepatide 2026: Ranked by Price and Care
The best telehealth providers for tirzepatide in 2026, ranked by price, protocol, and care quality. From $278/month compounded to brand Zepbound via insurance. No provider paid for placement.
Read guide →Is Compounded Semaglutide Legal and Safe in 2026?
Is compounded semaglutide still legal? We break down the current FDA rules, 30 new warning letters, SAFE Drugs Act, Hims exiting compounded, and what this means for your prescription.
Read guide →Compounded Tirzepatide 2026: What's Happening and What Patients Should Do
Compounded tirzepatide is under active FDA enforcement as of April 2026 — supply is declining but not yet at zero. The 503B enforcement discretion ended over a year ago (March 2025); the FDA has now issued 50+ warning letters including a 30-letter batch in April 2026. Here's what patients need to know and what to do.
Read guide →